These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 25631486

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S, Nakama T, Ishikawa K, Arima M, Tachibana T, Nakao S, Sassa Y, Yasuda M, Enaida H, Oshima Y, Kono T, Ishibashi T.
    Invest Ophthalmol Vis Sci; 2012 Oct 09; 53(11):6997-7003. PubMed ID: 22977138
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of vitreous inflammatory factors with diabetic macular edema.
    Funatsu H, Noma H, Mimura T, Eguchi S, Hori S.
    Ophthalmology; 2009 Jan 09; 116(1):73-9. PubMed ID: 19118698
    [Abstract] [Full Text] [Related]

  • 7. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy.
    Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, Sakamoto T, Nishida K.
    Graefes Arch Clin Exp Ophthalmol; 2009 Dec 09; 247(12):1617-24. PubMed ID: 19639332
    [Abstract] [Full Text] [Related]

  • 8. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S.
    Ophthalmology; 2003 Sep 09; 110(9):1690-6. PubMed ID: 13129863
    [Abstract] [Full Text] [Related]

  • 9. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
    Koss MJ, Pfister M, Rothweiler F, Michaelis M, Cinatl J, Schubert R, Koch FH.
    Acta Ophthalmol; 2012 Mar 09; 90(2):e98-e103. PubMed ID: 22066978
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R.
    Diabet Med; 2005 Jun 09; 22(6):719-22. PubMed ID: 15910622
    [Abstract] [Full Text] [Related]

  • 11. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy.
    Koskela UE, Kuusisto SM, Nissinen AE, Savolainen MJ, Liinamaa MJ.
    Ophthalmic Res; 2013 Jun 09; 49(2):108-14. PubMed ID: 23257933
    [Abstract] [Full Text] [Related]

  • 12. Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy.
    Yoshida S, Kobayashi Y, Nakao S, Sassa Y, Hisatomi T, Ikeda Y, Oshima Y, Kono T, Ishibashi T, Sonoda KH.
    Clin Ophthalmol; 2017 Jun 09; 11():1697-1705. PubMed ID: 29033535
    [Abstract] [Full Text] [Related]

  • 13. A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.
    Srividya G, Jain M, Mahalakshmi K, Gayathri S, Raman R, Angayarkanni N.
    Eye (Lond); 2018 Apr 09; 32(4):820-829. PubMed ID: 29303154
    [Abstract] [Full Text] [Related]

  • 14. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA.
    Exp Eye Res; 2006 May 09; 82(5):798-806. PubMed ID: 16324700
    [Abstract] [Full Text] [Related]

  • 15. Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S, Ishikawa K, Matsumoto T, Yoshida A, Ishibashi T, Kono T.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun 09; 248(6):799-804. PubMed ID: 20135140
    [Abstract] [Full Text] [Related]

  • 16. [Role of chemokines in the vitreous of proliferative diabetic retinopathy].
    Kawashima M, Shoji J, Kamura Y, Sato Y.
    Nippon Ganka Gakkai Zasshi; 2005 Sep 09; 109(9):596-602. PubMed ID: 16218438
    [Abstract] [Full Text] [Related]

  • 17. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M, Shoji J, Nakajima M, Kamura Y, Sato Y.
    Jpn J Ophthalmol; 2007 Sep 09; 51(2):100-4. PubMed ID: 17401618
    [Abstract] [Full Text] [Related]

  • 18. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct 09; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

  • 19. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.
    Chernykh VV, Varvarinsky EV, Smirnov EV, Chernykh DV, Trunov AN.
    Indian J Ophthalmol; 2015 Jan 09; 63(1):33-6. PubMed ID: 25686060
    [Abstract] [Full Text] [Related]

  • 20. Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.
    Urbančič M, Petrovič D, Živin AM, Korošec P, Fležar M, Petrovič MG.
    Mol Vis; 2020 Jan 09; 26():472-482. PubMed ID: 32606566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.